Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S341000, C546S325000, C546S325000, C548S364100, C548S366100, C548S366400, C548S366700, C548S369700, C548S370100, C548S370400, C548S370700
Reexamination Certificate
active
07109228
ABSTRACT:
This invention relates to pyrazole derivatives of formula (I)or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
REFERENCES:
patent: 3303200 (1967-02-01), Wolf et al.
patent: 3963742 (1976-06-01), Cross et al.
patent: 4000301 (1976-12-01), Walworth
patent: 4041046 (1977-08-01), Cross et al.
patent: 538156 (1993-04-01), None
patent: 0786455 (1997-07-01), None
patent: 658547 (1998-11-01), None
patent: 9111172 (1991-08-01), None
patent: 9402518 (1994-02-01), None
patent: 9422830 (1994-10-01), None
patent: 9429300 (1994-12-01), None
patent: 9602138 (1996-02-01), None
patent: 9855148 (1998-12-01), None
Dzvinchuk et al., Chemical Abstracts, vol. 112:77066, 1990.
Kato et al., Chemical Abstracts, vol. 108:93811, 1998.
Kirsten et al., Chemical Abstracts, vol. 105:60431, 1986.
Genin et al., J. Med. Chem., vol. 43 p. 1034-1040 (2000).
Berge et al., J. Pharm. Sci., vol. 66, pp. 1-19 (1977).
Ferres, Drugs of Today, vol. 19, No. 9, pp. 499-538 (1983).
Bundgaard, Elsevier, Design of Prodrugs, Chapter 1 (1985).
Attanasi et al., “Reaction of Some 1,2-Diaza-1,3-butadienes with Activated Methine Compounds. A Straightforward Entry to 1,4-Dihydropyridazine, Pyridazine, and 4,5(4H,5H)-Cyclopropylpyrazole Derivatives”, J. Org. Chem., 1998, 63, 9880-9887.
Beilstein Registry No. 331922 (Update Date May 13, 1992).
Lipinski et al., “Bronchodilator and Antiulcer Phenoxypyrimidinones”, L. Med. Chem., 1980, 23, 1026-1031.
Munch-Peterson and Hauser, “Acylations of Certain α-Alkoxy and α-Aryloxy Ketones and Esters”, J. Am. Chem. Soc., 71, 1949, 770-773.
Olsen, et al., “Synthesis of Functionalized Aryloxy 1,3-Butadienes and Their Transformation to Diaryl Ethers via Diels-Alder Cycloaddition Reactions”, J. Org. Chem., 1995, 60, 6025-6031.
Regitz and Schafer, “Stabile Enole von α-[Aryl(Alkl)oxy]dibenzoylmethanen”, Liebigs Ann Chem, 1981, 1172-1185.
Smodis and Stanovnik, “The Synthesis and Transformations of Substituted 2-Hydroxy-3-dimethylaminopropenoates. The Preparation of Condensed 3-Hydroxypyran-2-ones”, Tetrahedron 54, 1998, 9799-9810.
Jones Lyn Howard
Mowbray Charles Eric
Price David Anthony
Selby Matthew Duncan
Stupple Paul Anthony
Agouron Pharmaceuticals , Inc.
Hutchinson Keith D.
Raymond Richard L.
Richardson Peter C.
Zielinski Bryan C.
LandOfFree
Pyrazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3545331